Stada Arzneimittel AG - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Stada Arzneimittel AG Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Stada Arzneimittel AG(STADA). The Group's principal activity is to manufacture generic drugs. The Group operates through two core segments: Generics and Branded products. Through Generics segment, the Group offers medicines after the expiration of their patents at the same quality but for significantly lower prices. Through Branded Products segment, the Group focuses on multisource products with off-patent active ingredients. The Group's current branded products portfolio includes primarily non-prescription which are called over-the-counter products (OTC products), and in some national markets also prescription drugs. The non-core segment includes commercial business. The Group mainly operates in Europe, America and Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report